UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Potential therapeutic targets and promising drugs for combating SARS‐CoV‐2

British journal of pharmacology, 2020-07, Vol.177 (14), p.3147-3161

2020

Volltextzugriff (PDF)

DNA Related Enzymes as Molecular Targets for Antiviral and Antitumoral Chemotherapy. A Natural Overview of the Current Perspectives

Current drug targets, 2019-01, Vol.20 (1), p.70-80

2019

Volltextzugriff (PDF)

Spectrum of activity testing for therapeutics against all four dengue virus serotypes in AG129 mouse models: Proof-of-concept studies with the adenosine nucleoside inhibitor NITD-008

Antiviral research, 2018-06, Vol.154, p.104-109

2018

Volltextzugriff (PDF)

Direct-Acting Antivirals for Hepatitis C Virus (HCV): The Progress Continues

Current drug targets, 2017-01, Vol.18 (7), p.851-862

Feld, Jordan J

2017

Volltextzugriff (PDF)

Effects of nucleoside analogue prescription for hepatitis B on the incidence of liver cancer in Hong Kong: a territory‐wide ecological study

Alimentary pharmacology & therapeutics, 2017-02, Vol.45 (4), p.501-509

2017

Volltextzugriff (PDF)

Profiling of the kinome of cytomegalovirus-infected cells reveals the functional importance of host kinases Aurora A, ABL and AMPK

Antiviral research, 2013-08, Vol.99 (2), p.139-148

2013

Volltextzugriff (PDF)

Antiviral therapy: old and current issues

International journal of antimicrobial agents, 2012-08, Vol.40 (2), p.95-102

2012

Volltextzugriff (PDF)

DNA polymerase inhibitors for treating hepatitis B: a safety evaluation

Expert opinion on drug safety, 2016-03, Vol.15 (3), p.383-392

2016

Volltextzugriff (PDF)

Ritonavir and efavirenz significantly alter the metabolism of erlotinib--an observation in primary cultures of human hepatocytes that is relevant to HIV patients with cancer

Drug metabolism and disposition, 2013-10, Vol.41 (10), p.1843-1851

2013

Volltextzugriff (PDF)

Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity

Cancer chemotherapy and pharmacology, 2015-01, Vol.75 (1), p.59-66

2015

Volltextzugriff (PDF)

Monitoring of thiopurine metabolites – A high-performance liquid chromatography method for clinical use

Journal of pharmaceutical and biomedical analysis, 2013-03, Vol.75, p.145-152

2013

Volltextzugriff (PDF)

Role of rifampin-based combination therapy for severe community-acquired Legionella pneumophila pneumonia

The Annals of pharmacotherapy, 2011-07, Vol.45 (7-8), p.967-976

2011

Volltextzugriff (PDF)

DNA synthesis inhibitors for the treatment of gastrointestinal cancer

Expert opinion on pharmacotherapy, 2014-11, Vol.15 (16), p.2361-2372

2014

Volltextzugriff (PDF)

Serum hepatitis B surface antigen kinetics in severe reactivation of hepatitis B e antigen negative chronic hepatitis B patients receiving nucleoside/nucleotide analogues

Antiviral therapy, 2013-01, Vol.18 (8), p.979-986

2013

Volltextzugriff (PDF)

Inhibition of DNA synthesis by Carvacrol in mouse myoblast cells bearing a human N-RAS oncogene

Phytomedicine (Stuttgart), 2003-05, Vol.10 (4), p.292-299

2003

Volltextzugriff (PDF)

New antibacterial agents: patent applications published in 2011

Pharmaceutical patent analyst, 2014-01, Vol.3 (1), p.87-112

2014

Volltextzugriff (PDF)

Strong inhibition of replicative DNA synthesis in the developing rat cerebral cortex and glioma cells by roscovitine

Investigational new drugs, 2010-06, Vol.28 (3), p.299-305

2010

Volltextzugriff (PDF)

Filibuvir, a non-nucleoside NS5B polymerase inhibitor for the potential oral treatment of chronic HCV infection

IDrugs : the investigational drugs journal, 2010-12, Vol.13 (12), p.938

Beaulieu, Pierre L

2010

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of hydroxyurea

Clinical pharmacokinetics, 1998-05, Vol.34 (5), p.347-358

1998

Volltextzugriff (PDF)

Pharmacogenetics of Crohn's disease

Pharmacogenomics, 2008-07, Vol.9 (7), p.881-893

2008

Volltextzugriff (PDF)

Immunosuppressive drugs as an adjuvant to HIV treatment

Journal of antimicrobial chemotherapy, 2004-03, Vol.53 (3), p.415-417

2004

Volltextzugriff (PDF)

A randomized trial to investigate the recycling of stavudine and didanosine with and without hydroxyurea in salvage therapy (RESTART)

Journal of antimicrobial chemotherapy, 2004-03, Vol.53 (3), p.501-505

2004

Volltextzugriff (PDF)

In vivo antitumor efficacy and cardiotoxicity of novel anthracycline ID6105 (11-hydroxy-aclacinomycin X, Hyrubicin)

Cancer chemotherapy and pharmacology, 2006-06, Vol.57 (6), p.811-818

2006

Volltextzugriff (PDF)

New uses for old drugs in HIV infection : The role of hydroxyurea, cyclosporin and thalidomide

Drugs (New York, N.Y.), 1999-12, Vol.58 (6), p.953-963

1999

Volltextzugriff (PDF)

Conventional treatment of hypercalcemia of malignancy

American journal of health-system pharmacy, 2001-11, Vol.58 (suppl 3), p.S8-S15

Davidson, TG

2001

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Aktive Filter

KollektionBMJ

ThemaPharmacology & Pharmacy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(82)

Sprache

Englisch
(82)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(82)
Science & Technology
(82)
Humans
(71)
Animals
(39)
Biological And Medical Sciences
(39)
Nucleic Acid Synthesis Inhibitors
(39)
Medical Sciences
(38)
Pharmacology. Drug Treatments
(37)
Antiviral Agents - Therapeutic Use
(32)
Nucleic Acid Synthesis Inhibitors - Therapeutic Use
(32)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(27)
Antiviral Agents - Pharmacology
(24)
Antiviral Agents
(23)
Female
(20)
Male
(18)
Infectious Diseases
(17)
Microbiology
(17)
Mice
(15)
Chemistry, Medicinal
(13)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Potential therapeutic targets and promising drugs for combating SARS‐CoV‐2

DNA Related Enzymes as Molecular Targets for Antiviral and Antitumoral Chemotherapy. A Natural Overview of the Current Perspectives

Spectrum of activity testing for therapeutics against all four dengue virus serotypes in AG129 mouse models: Proof-of-concept studies with the adenosine nucleoside inhibitor NITD-008

Direct-Acting Antivirals for Hepatitis C Virus (HCV): The Progress Continues

Effects of nucleoside analogue prescription for hepatitis B on the incidence of liver cancer in Hong Kong: a territory‐wide ecological study

Profiling of the kinome of cytomegalovirus-infected cells reveals the functional importance of host kinases Aurora A, ABL and AMPK

Antiviral therapy: old and current issues

DNA polymerase inhibitors for treating hepatitis B: a safety evaluation

Ritonavir and efavirenz significantly alter the metabolism of erlotinib--an observation in primary cultures of human hepatocytes that is relevant to HIV patients with cancer

Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity

Monitoring of thiopurine metabolites – A high-performance liquid chromatography method for clinical use

Role of rifampin-based combination therapy for severe community-acquired Legionella pneumophila pneumonia

DNA synthesis inhibitors for the treatment of gastrointestinal cancer

Serum hepatitis B surface antigen kinetics in severe reactivation of hepatitis B e antigen negative chronic hepatitis B patients receiving nucleoside/nucleotide analogues

Inhibition of DNA synthesis by Carvacrol in mouse myoblast cells bearing a human N-RAS oncogene

New antibacterial agents: patent applications published in 2011

Strong inhibition of replicative DNA synthesis in the developing rat cerebral cortex and glioma cells by roscovitine

Filibuvir, a non-nucleoside NS5B polymerase inhibitor for the potential oral treatment of chronic HCV infection

Pharmacokinetics and pharmacodynamics of hydroxyurea

Pharmacogenetics of Crohn's disease

Immunosuppressive drugs as an adjuvant to HIV treatment

A randomized trial to investigate the recycling of stavudine and didanosine with and without hydroxyurea in salvage therapy (RESTART)

In vivo antitumor efficacy and cardiotoxicity of novel anthracycline ID6105 (11-hydroxy-aclacinomycin X, Hyrubicin)

New uses for old drugs in HIV infection : The role of hydroxyurea, cyclosporin and thalidomide

Conventional treatment of hypercalcemia of malignancy

Aktive Filter

Suchergebnisse filtern